Available 24 hours a day,
7 days a week.
Call: 800-800-8888 Now
The Hammer’s Guarantee: You will pay nothing until we win or settle your case
Why Choose Us?
We Get Results:
$4 Million
$700,000
$2.2 Million
$1.5 Million
If you’ve taken Zantac (Ranitidine) and subsequently developed cancer, our assembled team of attorneys can help you get the justice and compensation you rightfully deserve. Our Zantac law firm has handled a growing number of lawsuits involving pharmaceutical toxins. They’ll fight to ensure you receive the maximum money damages possible. It’s time to hold the drug makers accountable for their blatant willingness to put profit before people’s health.
Get started today on your Zantac lawsuit by calling Isaacs and Isaacs at 800-800-8888 or fill out our free case review form below.
Antacid drugs are among some of the most commonly taken drugs in the USA. One of these drugs, Zantac (Ranitidine in its generic form), which is regularly taken by millions, has been recently identified as having a cancer-causing ingredient nearly 3,000 times more than the FDA’s recommended daily limit.
On April 1, 2020, the U.S. Food and Drug Administration announced it is “requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac).”
Growing evidence suggests that pharmaceutical company Sanofi and Boehringer Ingelheim, manufacturer of Zantac, allegedly concealed Zantac’s cancer link despite knowledge of its potential cancer-causing effects. Meanwhile the company generated sales of over $1 billion in profit.
Past users of Zantac are now filing Zantac lawsuits in order to hold Sanofi and Boehringer Ingelheim accountable for blatant disregard for the health of their consumers and endangering the lives of countless numbers of people.
On September 13, 2019, the FDA announced that it had been discovered that some Ranitidine medications contained N-nitrosodimethylamine (NDMA). The World Health Organization has classified NDMA as a ‘probable human carcinogen’ i.e. a substance that could cause cancer. On November 1, 2019, Novartis (via its generic division, Sandoz) and Apotex announced that they were recalling all generic ranitidine products they sell in the US.
Following the FDA news, on October 1, 2019, CVS and Walgreens announced they would be pulling Zantac and generic versions of ranitidine. The recall includes Zantac 150®, Zantac 150® Cool Mint, and Zantac 75®.
The FDA lists regular Zantac recall updates.
Since the 1980’s there have been several studies that put forward the case that Zantac causes cancer. According to the World Health Organization (WHO), “NDMA is clearly carcinogenic. There is overwhelming evidence that NDMA is mutagenic and clastogenic.”
The Environmental Protection Agency (EPA) also identified NDMA as belonging to a family of chemicals called N-Nitro-samines, which they describe as “potent carcinogens”.
Carcinogenic effects of NDMA exposure potentially include:
Representatives are available 24 hours a day, 7 days a week. Call 800-800-8888 Now!
More than 27 years of personal Injury law experience.
Former prosecutors who know how the "other side" operates.
Get 100% Personalized, one-on-one attention for your case.
Hammer Tough negotiators and proven trial lawyers.
Accessibility and availability – clients can always reach our attorneys.
If you, or someone you love, developed cancer following use of Zantac on a regular basis, you should speak to Isaacs & Isaacs today. We’ll make sure you have an experienced team of Zantac attorneys fighting to get you financial compensation for losses including:
To ensure you have the best chance of winning your case, you need lawyers with experience in winning defective drug cases. Our dedicated team of Zantac attorneys will work hard to demand the maximum settlement possible for you.
Get a no-cost claim review to see if you are eligible for compensation. Call Isaacs and Isaacs 24/7 at 800-800-8888 or complete the form below.
Zantac (Ranitidine in its generic form) has been identified as containing a cancer-causing ingredient nearly 3,000 times more than the FDA’s recommended daily limit.
Timeline of Zantac recall:
The World Health Organization classifies chemicals contained in Zantac and some generic versions as a probable human carcinogen. They note that exposure to high amounts of N-nitrosodimethylamine (NDMA) has links to causing colorectal or gastric cancer.
